ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 686505 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 686505; 2) Community: the network communities that were significantly associated with the response to NSC 686505; 3) Molecule: the relationships between components within communities and NSC 686505; 4) MDR: the compounds that were significantly associated with the NSC 686505.

NSC Compound Enrichment Correlation
NSC 320846 Batracylin, Daniquidone 0.0421163101172308 0.25023741
NSC 333054 Adriamycin, tetrahydropyranyl 0.0421163101172308 0.44959427
NSC 349447 Indolo[2,1-b]quinazoline-6,12-dione (8CI9CI) 0.0421163101172308 0.36615134
NSC 368891 Null 0.0421163101172308 0.28504082
NSC 381811 Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-[[3- (5-fluoro-1,2,3,4-tetrahydro-2,4-dioxo-1-pyrimidinyl)- 1-oxopropyl]oxy]- 0.0421163101172308 0.13400692
NSC 48229 Null 0.0421163101172308 -0.1581622
NSC 48300 ANTINEOPLASTIC-48300 0.0421163101172308 0.24910331
NSC 529108 4-Fluoro-D,L-tryptophan 0.0421163101172308 0.32189605
NSC 58905 9H-Purine, 9-(2-chloroethyl)-6-[(phenylmethyl)thio]- (9CI) 0.0421163101172308 0.31571823
NSC 610456 Camptothecin Derivative 0.0421163101172308 0.45145899
Total:93  Current:83    [First] [Prev] [Next] [Last]